Utility Therapeutics Ltd. | WebDisclosure

Basculer en Français

9547	Companies
188173	Keywords
120057	Articles
100509	Press releases

Headlines Articles Press releases Utility Therapeutics Ltd.

Home
Companies
Utility Therapeutics Ltd.

PRESS RELEASE

published on 01/17/2024 at 12:00, 1 year 11 months ago

UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review
UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com.

UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval

Accesswire

Published on 12/18/2025 at 00:55, 3 hours ago

Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 55 minutes ago

Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 40 minutes ago

Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 55 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 55 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy

View all ACCESSWIRE

EQS Group

Published on 12/18/2025 at 01:10, 2 hours 45 minutes ago

Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 5 minutes ago

Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 50 minutes ago

Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 50 minutes ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 33 minutes ago

EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share

Les Echos

Published on 12/17/2025 at 20:39, 7 hours 16 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 16 minutes ago

Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 25 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 19:30, 8 hours 25 minutes ago

Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 55 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE